In an adult patient without known drug allergies, when should I choose ceftriaxone versus cefixime versus amoxicillin versus azithromycin for bacterial infections?

Antibiotic Selection: Ceftriaxone vs Cefixime vs Amoxicillin vs Azithromycin

For most serious bacterial infections requiring empiric therapy in adults, ceftriaxone is the preferred choice due to its superior CNS penetration, broader spectrum, once-daily dosing, and proven efficacy in life-threatening infections; reserve cefixime for outpatient urinary/respiratory infections, amoxicillin for specific pathogens (Listeria, penicillin-sensitive organisms) or age ≥60 with suspected meningitis, and azithromycin primarily for atypical respiratory pathogens or gonorrhea when cephalosporins are unavailable.

Clinical Decision Algorithm

Step 1: Assess Infection Severity and Site

Severe/Life-Threatening Infections (Meningitis, Sepsis, Bacteremia):

• Choose Ceftriaxone 2g IV q12-24h 1
• For meningitis in adults <60 years: Ceftriaxone 2g IV q12h OR Cefotaxime 2g IV q6h 1
• For meningitis in adults ≥60 years: Add Amoxicillin 2g IV q4h to cover Listeria 1
• Ceftriaxone provides sustained bactericidal levels and excellent CSF penetration

Moderate Infections (Hospitalized Patients):

• Community-acquired pneumonia: Ceftriaxone 2g daily + macrolide (clarithromycin preferred over azithromycin due to fewer adverse events) 2, 3
• Skin/soft tissue infections: Ceftriaxone is safe and effective for staphylococcal/streptococcal infections 4
• Ceftriaxone demonstrated equivalent or superior outcomes compared to combination therapies 5

Mild Outpatient Infections:

• Uncomplicated UTI/respiratory infections: Cefixime 400mg PO daily 6
• Pharyngitis/tonsillitis: Cefixime 400mg daily (though penicillin remains drug of choice for Strep pyogenes) 6
• Cefixime achieves 97.4% cure rate for urogenital infections but provides lower bactericidal levels than ceftriaxone 7, 8

Step 2: Identify Specific Pathogen Considerations

Neisseria gonorrhoeae (Gonorrhea):

• First-line: Ceftriaxone 250mg IM single dose + Azithromycin 1g PO single dose 9
• If ceftriaxone unavailable: Cefixime 400mg PO + Azithromycin 1g PO + test-of-cure in 1 week 9
• Severe cephalosporin allergy: Azithromycin 2g PO single dose + test-of-cure 9
• Critical: Cefixime is NO LONGER recommended as first-line due to rising resistance 9

Listeria monocytogenes:

• Amoxicillin 2g IV q4h for 21 days 1
• Essential coverage in adults ≥60 years with meningitis 1
• Alternative: Co-trimoxazole if penicillin-allergic 1

Atypical Respiratory Pathogens (Mycoplasma, Chlamydophila, Legionella):

• Azithromycin or levofloxacin/moxifloxacin 2
• For CAP: Combine β-lactam (ceftriaxone) + macrolide for better outcomes 2, 3
• Azithromycin preferred over erythromycin (fewer GI adverse events) 3

Streptococcus pneumoniae:

• Penicillin-sensitive: Ceftriaxone, cefotaxime, or benzylpenicillin 1
• Penicillin-resistant but cephalosporin-sensitive: Continue ceftriaxone 1
• Dual resistance: Ceftriaxone + vancomycin + rifampicin 1

Step 3: Route of Administration Considerations

Parenteral (IV/IM) Required:

• Ceftriaxone: Once-daily dosing advantage, long half-life 4
• Maintains bactericidal activity 100% of dosing interval against S. pneumoniae, H. influenzae, M. catarrhalis 8
• Cost-effective: £107 cheaper per patient than combination therapy, saves 40 minutes nursing time daily 5

Oral Therapy Appropriate:

• Cefixime: Maintains >50% time above MIC for respiratory pathogens but does NOT maintain bactericidal activity against S. pneumoniae 8
• Amoxicillin: 750-1750mg/day divided q8-12h for susceptible organisms 10
• Azithromycin: 500mg daily for 5-7 days for atypical pathogens 11

Step 4: Special Populations

Pediatric Patients (≥6 months):

• Cefixime: 8mg/kg/day (max 400mg) 6
• Amoxicillin: 20-45mg/kg/day divided q8-12h 10
• For meningitis: Same ceftriaxone dosing as adults (2g q12h) 1

Pregnant Patients:

• Avoid doxycycline, quinolones, tetracyclines 12
• For Chlamydia: Azithromycin 1g PO single dose OR Amoxicillin 500mg PO TID x7 days 12

Renal Impairment:

• Reduce amoxicillin dose if GFR <30 mL/min 10
• Ceftriaxone: No dose adjustment needed (dual hepatic/renal elimination)

Key Comparative Advantages

Ceftriaxone Superiority:

• Once-daily dosing improves compliance
• Superior CNS penetration for meningitis 1
• Broader spectrum including resistant organisms
• Cost-effective compared to combination therapy 5
• 99.1% cure rate for urogenital/anorectal infections 7

Cefixime Limitations:

• Lower bactericidal levels than ceftriaxone 7, 8
• Does NOT maintain bactericidal activity against S. pneumoniae 8
• Rising resistance in gonorrhea—no longer first-line 9
• Requires test-of-cure when used for gonorrhea 9

Amoxicillin Niche Uses:

• Essential for Listeria coverage (age ≥60, meningitis) 1
• Penicillin-sensitive organisms when narrowing spectrum
• H. pylori eradication (triple/dual therapy) 10

Azithromycin Specific Roles:

• Mandatory combination with ceftriaxone for gonorrhea 9
• Atypical respiratory pathogens 2
• Single-dose convenience for Chlamydia 12
• Caution: Cardiovascular adverse events limit use 3

Critical Pitfalls to Avoid

1. Never use cefixime alone for gonorrhea—always combine with azithromycin and consider test-of-cure 9
2. Never use cefixime for meningitis—inadequate CNS penetration
3. Never omit amoxicillin in adults ≥60 with suspected meningitis—Listeria coverage essential 1
4. Never use azithromycin monotherapy for serious infections—reserve for specific indications 3
5. Never assume cefixime provides same efficacy as ceftriaxone—lower bactericidal activity 8

Treatment Duration

• Meningococcal meningitis: 5 days if recovered 1
• Pneumococcal meningitis: 10 days if stable, up to 14 days if slow response 1
• Listeria meningitis: 21 days 1
• CAP: Generally ≤8 days in responding patients 2
• Gonorrhea: Single dose (ceftriaxone + azithromycin) 9